Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose L Castro

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Annals of Thoracic Surgery|November 7, 2003
Hypereosinophilic thrombus causing aortic stenosis and myocardial infarctionMichael G D'Souza, Daniel G Swistel, Jose L Castro, et al.
Journal of Medicinal Chemistry|June 22, 2022
Rings in Clinical Trials and Drugs: Present and FutureJonathan Shearer, Jose L Castro, Alastair D G Lawson, et al.
Journal of Colloid and Interface Science|March 8, 2013
Surface-enhanced Raman scattering of picolinamide, nicotinamide, and isonicotinamide: unusual carboxamide deprotonation under adsorption on silver nanoparticlesJose L Castro, Juan F Arenas, Maria R Lopez-Ramirez, et al.
World Journal of Gastroenterology|March 23, 2006
Altered blood-brain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is loweredFrancisco Eizayaga, Camila Scorticati, Juan-P Prestifilippo, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IJason M Elliott, Jose L Castro, Gary G Chicchi, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IILaura C Cooper, Emma J Carlson, Jose L Castro, et al.
Journal of Medicinal Chemistry|January 11, 2002
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonistsStephen R Fletcher, Frank Burkamp, Peter Blurton, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Annals of Thoracic Surgery|November 7, 2003
Hypereosinophilic thrombus causing aortic stenosis and myocardial infarctionMichael G D'Souza, Daniel G Swistel, Jose L Castro, et al.
Journal of Medicinal Chemistry|June 22, 2022
Rings in Clinical Trials and Drugs: Present and FutureJonathan Shearer, Jose L Castro, Alastair D G Lawson, et al.
Journal of Colloid and Interface Science|March 8, 2013
Surface-enhanced Raman scattering of picolinamide, nicotinamide, and isonicotinamide: unusual carboxamide deprotonation under adsorption on silver nanoparticlesJose L Castro, Juan F Arenas, Maria R Lopez-Ramirez, et al.
World Journal of Gastroenterology|March 23, 2006
Altered blood-brain barrier permeability in rats with prehepatic portal hypertension turns to normal when portal pressure is loweredFrancisco Eizayaga, Camila Scorticati, Juan-P Prestifilippo, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IJason M Elliott, Jose L Castro, Gary G Chicchi, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IILaura C Cooper, Emma J Carlson, Jose L Castro, et al.
Journal of Medicinal Chemistry|January 11, 2002
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonistsStephen R Fletcher, Frank Burkamp, Peter Blurton, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 1